BNTX Biontech SE
Health Care, filed as BIONTECH SE (SPONSORED ADS), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab
In 2026 Q2 Dodge & Cox and Cathie Wood added to Biontech.
Who owns this now
Largest portfolio weights among holders, up to 2.1% (Michael Krensavage, Krensavage Asset Management). Not free-float ownership.
Who owns BNTX
Sorted by value, long equity only, as of 2026 Q2.
| History | |||||
|---|---|---|---|---|---|
| Dodge & Cox | Add 0.0% | 3,677,591 | $342M | History | |
| Cathie Wood, Ark Investment Management | Add +4.3% | 133,333 | $12M | History | |
| Michael Krensavage, Krensavage Asset Management | Hold | 59,523 | $5.5M | History | |
| Palo Alto Investors | Hold | 19,614 | $1.8M | History | |
| Nathan Fischel, Dafna Capital Management | Hold | 7,000 | $651K | History | |
| Ron Baron, Bamco Inc. (Baron Capital) | Hold | 776 | $72K | History |
Insider trades
Open-market buys and sales by BNTX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- None no sales outside a trading plan
- $89.8M sold by 2 insiders under 10b5-1 plans
-
Ugur Sahin CEOPlanned sale$5.9M 63,209 shares at $94.07 100% of stakeTraded Oct 8–9 Filed Oct 9
-
Ugur Sahin CEOPlanned sale$2.3M 24,000 shares at $95.86 28% of stakeTraded Oct 7 Filed Oct 7
-
Ugur Sahin CEOPlanned sale$9M 93,000 shares at $97.14 52% of stakeTraded Oct 5–6 Filed Oct 6
-
Ugur Sahin CEOPlanned sale$3.3M 34,000 shares at $97.09 16% of stakeTraded Oct 1–2 Filed Oct 2
-
Ugur Sahin CEOPlanned sale$6.5M 66,000 shares at $98.19 24% of stakeTraded Sep 29–30 Filed Sep 30
-
Ugur Sahin CEOPlanned sale$6M 61,000 shares at $98.57 18% of stakeTraded Sep 25–28 Filed Sep 28
-
Ugur Sahin CEOPlanned sale$6.8M 69,000 shares at $99.17 17% of stakeTraded Sep 23–24 Filed Sep 24
-
Ugur Sahin CEOPlanned sale$7.9M 79,000 shares at $99.50 16% of stakeTraded Sep 21–22 Filed Sep 22
-
Ugur Sahin CEOPlanned sale$6.2M 64,000 shares at $97.49 12% of stakeTraded Sep 17–18 Filed Sep 18
-
Ugur Sahin CEOPlanned sale$4.7M 49,000 shares at $96.37 8.1% of stakeTraded Sep 15–16 Filed Sep 16
-
Ugur Sahin CEOPlanned sale$8.4M 86,000 shares at $98.13 13% of stakeTraded Sep 11–14 Filed Sep 14
-
Ugur Sahin CEOPlanned sale$2M 20,500 shares at $96.31 2.9% of stakeTraded Sep 10 Filed Sep 11
-
Ugur Sahin CEOPlanned sale$7.2M 73,000 shares at $98.50 9.3% of stakeTraded Sep 8–9 Filed Sep 9
-
Ugur Sahin CEOPlanned sale$7.9M 76,500 shares at $103.12 8.9% of stakeTraded Sep 3–4 Filed Sep 8
-
Sierk Poetting COOPlanned sale$5.5M 50,000 shares at $110.56 11% of stakeTraded Apr 22 Filed Apr 23
Congress
2 members of Congress traded BNTX in the last three years: 4 buys and 4 sales.
-
Val T. Hoyle
Sell
$1K–$15K
Aug 7, 2025
filed Sep 12, 2025
-
Josh Gottheimer
Sell
$1K–$15K
Sep 3, 2024
filed Oct 3, 2024
-
Josh Gottheimer
Partial sale
$1K–$15K
Aug 30, 2024
filed Sep 11, 2024
-
Josh Gottheimer
Buy
$1K–$15K
Apr 15, 2024
filed May 15, 2024
-
Josh Gottheimer
Sell
$1K–$15K
Mar 14, 2024
filed Apr 7, 2024
-
Josh Gottheimer
Buy
$1K–$15K
Dec 7, 2023
filed Jan 7, 2024
SEC filings
Recent issuer filings from EDGAR, 21 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 20-F/A | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc |
No filings match this filter.
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.